Showing results (101-110 of 168) with videos related to
Sort By:
Pageof 17
Experientia|November 15, 1984
The pharmacology of Parkinson's disease: basic aspects and recent advancesM Da Prada, H H Keller, L Pieri, et al.Journal of Neural Transmission. Supplementum|January 1, 1990
Monoamine oxidase inhibition by moclobemide and 2-amino-ethyl carboxamide derivatives: mode of action and kinetic characteristicsA M Cesura, D Muggli-Maniglio, G Lang, et al.Molecular Pharmacology|March 1, 1990
Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-AA M Cesura, M Bös, M D Galva, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Some basic aspects of reversible inhibitors of monoamine oxidase-AM Da Prada, R Kettler, W P Burkard, et al.Journal of Pharmacological Methods|June 1, 1981
Blood sampling by chronic cannulation technique for reliable measurements of catecholamines and other hormones in plasma of conscious ratsM O Carruba, G B Picotti, P Miodini, et al.British Journal of Pharmacology|November 1, 1981
Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbitsF Gudat, A Laubscher, U Otten, et al.Molecular Pharmacology|December 1, 1985
Activation of human blood platelets by arginine-vasopressin. Role of bivalent cationsA Pletscher, P Erne, E Bürgisser, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1984
Ca2+ as messenger of 5HT2-receptor stimulation in human blood plateletsH Affolter, P Erne, E Bürgisser, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
The effects of lifelong treatment with MAO inhibitors on amino acid levels in rat brainM Strolin Benedetti, R Kettler, P Marrari, et al.Journal of Neurochemistry|July 1, 1992
Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592E Acquas, E Carboni, R H de Ree, et al.Pageof 17